CAHP Statement: California Senate Votes on Widely-Supported Drug Price Transparency Bill
The California State Senate Committee on Health is set to vote today on SB 17, which responds to growing concerns over the impacts of drug companies’ efforts to push the limits on prescription drug prices that have left California families and state programs grappling with the realities of six-figure price tags for common medications.
Runaway Rx: Infographic – SB 17: Transparency in Drug Pricing
Runaway Rx: Infographic - SB 17: Transparency in Drug Prici…
Runaway Rx: Bipartisan Support for Drug Price Transparency
Runaway Rx: Bipartisan Support for Drug Price Transparency
CAHP Fact Sheet: New Health Care Mandates Would Drive Up Premiums By $943 Million
CAHP Fact Sheet: Say No to SB 598: A Prescription for Low-Value Healthcare